AXCAN Pharma(AXCA)..A GUT FEELING! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXCAN Pharma(AXCA)..A GUT FEELING!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (15)	8/19/2000 11:08:02 PM
From: Arthur Radley	of 46

Peter, I must admit that I got a chuckle out of the Pat Buchanan comment.(:>) The gall of that man! Can't disagree with your points on Urso for gallstone treatment. However, it is the other potential areas that I find interesting. From the annual report it appears that they have trials going on for the following: 1) non-alcoholic steatohepatis 2) recurrence of colorectal polyps(this 600 patient trial should have results released within weeks) 3) primary sclerosing cholangitis 4) primary hypercholesterolemia(results due by end of year) It appears that from the biliary cirrhosis trials they noted that patients had a decrease of total serum cholesterol levels. It is this potential that has my attention..being I'm a Zocor user myself.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next